EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol for establishing inducible CRISPR interference system for multiple-gene silencing in human pluripotent stem cells

Satoshi Matsui, Joseph R Shiley, Marissa Granitto, Katie Ludwig, Morgan Buckley, Sandra Koigi, Gerardo Mirizio, Yueh-Chiang Hu, Christopher N Mayhew, Makiko Iwafuchi

STAR Protocols · 2024

DOI: 10.1016/j.xpro.2024.103221 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2024. Verfasst von Satoshi Matsui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Developmental Biology, Center for Stem Cell & Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Department of…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Induced Pluripotent Stem Cells, RNA, Guide, CRISPR-Cas Systems, Gene Silencing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inducible loss-of-function strategies are crucial for understanding gene function. However, creating inducible, multiple-gene knockout models is challenging and time-consuming. Here, we present a protocol for establishing a doxycycline-inducible CRISPR interference (CRISPRi) system to concurrently silence multiple genes in human induced pluripotent stem cells (hPSCs). We describe the steps for establishing host CRISPRi hPSCs, designing and cloning single-guide RNAs (sgRNAs) into a lentivirus plasmid, and establishing monoclonal CRISPRi hPSC lines transduced with sgRNAs. We also detail the procedures for selecting effective CRISPRi clones. For complete details on the use and execution of this protocol, please refer to Matsui et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsInduced Pluripotent Stem CellsRNA, Guide, CRISPR-Cas SystemsGene SilencingHumansLentivirusClustered Regularly Interspaced Short Palindromic RepeatsPluripotent Stem CellsDoxycycline

Stichwörter der Autor:innen

CRISPRCell BiologyCell DifferentiationCell cultureCell isolationMolecular BiologyStem Cells

Substanzen

RNA, Guide, CRISPR-Cas SystemsDoxycycline

Autor:innen und Institutionen

  • Division of Developmental Biology, Center for Stem Cell & Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati…

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIH
  • Japan Society for the Promotion of Science
  • Uehara Memorial Foundation
  • Cincinnati Children’s Research Foundation

Zitieren

APA

Matsui, S., Shiley, J. R., Granitto, M., Ludwig, K., Buckley, M., Koigi, S., Mirizio, G., Hu, Y. C., Mayhew, C. N., & Iwafuchi, M. (2024). Protocol for establishing inducible CRISPR interference system for multiple-gene silencing in human pluripotent stem cells. STAR Protocols. https://doi.org/10.1016/j.xpro.2024.103221

Vancouver

Matsui S, Shiley JR, Granitto M, Ludwig K, Buckley M, Koigi S, et al. Protocol for establishing inducible CRISPR interference system for multiple-gene silencing in human pluripotent stem cells. STAR Protocols. 2024. doi:10.1016/j.xpro.2024.103221

BibTeX
@article{Matsui2024,
  author = {Matsui, Satoshi and Shiley, Joseph R and Granitto, Marissa and Ludwig, Katie and Buckley, Morgan and Koigi, Sandra and Mirizio, Gerardo and Hu, Yueh-Chiang and Mayhew, Christopher N and Iwafuchi, Makiko},
  title = {Protocol for establishing inducible CRISPR interference system for multiple-gene silencing in human pluripotent stem cells},
  journal = {STAR Protocols},
  year = {2024},
  doi = {10.1016/j.xpro.2024.103221}
}
Kostenlos starten →